Research & Development

Photo: Elizabeth Poll/MMV

MMV-supported projects

Established in 1999 to reignite stalled research and development into malaria medicines, MMV has since built the richest malaria drug pipeline in history, with 13 antimalarials now treating patients. These medicines have contributed to saving more than 2.2 million lives over the past two decades. The portfolio includes new drugs in clinical development addressing unmet medical needs in malaria, including medicines for children, pregnant women and relapsing malaria, and drugs that could support the elimination/eradication agenda.